{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:02:24Z","timestamp":1771488144377,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ypmed.2017.07.027","type":"journal-article","created":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T15:46:06Z","timestamp":1501343166000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Surveillance of high-grade cervical cancer precursors (CIN III\/AIS) in four population-based cancer registries, United States, 2009\u20132012"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3343-6794","authenticated-orcid":false,"given":"Meg","family":"Watson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini","family":"Soman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine W.","family":"Flagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Unger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Deapen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren C.","family":"Peres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Garnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Saraiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2017.07.027_bb0005","unstructured":"[North] American Association of Central Cancer Registries n.d. Working group on pre-invasive cervical neoplasia and population-based cancer registries: final subcommittee report. [N]AACCR conference held 5\u20136 Apr 1993, Rockville, MD. Subsequently adopted by the [N]AACCR Executive Board May 1993 and amended November 1993."},{"issue":"10","key":"10.1016\/j.ypmed.2017.07.027_bb0010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/jwh.2011.3385","article-title":"Cervical cancer trends in the United States: a 35-year population-based analysis","volume":"21","author":"Adegoke","year":"2012","journal-title":"J. Women's Health (Larchmt)"},{"key":"10.1016\/j.ypmed.2017.07.027_bb0015","author":"American Society for Colposcopy and Clinical Pathology"},{"issue":"44","key":"10.1016\/j.ypmed.2017.07.027_bb0020","first-page":"1004","article-title":"Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007\u20132012","volume":"63","author":"Benard","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"5","key":"10.1016\/j.ypmed.2017.07.027_bb0025","first-page":"303","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsague","year":"2006","journal-title":"JNCI Cancer Spectrum"},{"issue":"3","key":"10.1016\/j.ypmed.2017.07.027_bb0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"51\u201352","key":"10.1016\/j.ypmed.2017.07.027_bb0035","first-page":"1038","article-title":"Cervical cancer screening among women aged 18\u201330years - United States, 2000\u20132010","volume":"61","author":"Centers for Disease C, Prevention","year":"2013","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2017.07.027_bb0040","series-title":"Tobacco Control State Highlights","author":"Centers for Disease Control and Prevention","year":"2012"},{"key":"10.1016\/j.ypmed.2017.07.027_bb0045","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ypmed.2017.07.027_bb0050","series-title":"Behavioral Risk Factor Surveillance System: prevalence data and data analysis tools","author":"Centers for Disease Control and Prevention","year":"2016"},{"issue":"6","key":"10.1016\/j.ypmed.2017.07.027_bb0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jpag.2013.06.013","article-title":"The prevalence of HPV associated cervical intraepithelial neoplasia in women under age 21: who will be missed under the new cervical cancer screening guidelines?","volume":"26","author":"DeCew","year":"2013","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"8","key":"10.1016\/j.ypmed.2017.07.027_bb0060","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003\u20132010: potential impact of human papillomavirus vaccination","volume":"103","author":"Flagg","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"5","key":"10.1016\/j.ypmed.2017.07.027_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10552-014-0362-x","article-title":"Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009","volume":"25","author":"Flagg","year":"2014","journal-title":"Cancer Causes Control"},{"issue":"16","key":"10.1016\/j.ypmed.2017.07.027_bb0070","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.29266","article-title":"Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States","volume":"121","author":"Hariri","year":"2015","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ypmed.2017.07.027_bb0080","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3201\/eid2109.141841","article-title":"Monitoring effect of human papillomavirus vaccines in US population, emerging infections program, 2008-2012","volume":"21","author":"Hariri","year":"2015","journal-title":"Emerg. Infect. Dis."},{"issue":"13","key":"10.1016\/j.ypmed.2017.07.027_bb0090","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.vaccine.2015.01.084","article-title":"Reduction in HPV 16\/18-associated high grade cervical lesions following HPV vaccine introduction in the United States \u2013 2008\u20132012","volume":"33","author":"Hariri","year":"2015","journal-title":"Vaccine"},{"issue":"9509","key":"10.1016\/j.ypmed.2017.07.027_bb0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ypmed.2017.07.027_bb0100","first-page":"31","article-title":"Predictors of cervical cancer screening adherence in the United States: a systematic review","volume":"5","author":"Limmer","year":"2014","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.ypmed.2017.07.027_bb0105","series-title":"Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports\/centers for Disease Control","first-page":"1","volume":"56(RR-2)","author":"Markowitz","year":"2007"},{"issue":"3","key":"10.1016\/j.ypmed.2017.07.027_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003\u20132010","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ypmed.2017.07.027_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2015-1968","article-title":"Prevalence of HPV after introduction of the vaccination program in the United States","volume":"137","author":"Markowitz","year":"2016","journal-title":"Pediatrics"},{"issue":"Suppl. 5","key":"10.1016\/j.ypmed.2017.07.027_bb0120","doi-asserted-by":"crossref","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","article-title":"Updating the natural history of human papillomavirus and anogenital cancers","volume":"30","author":"Moscicki","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ypmed.2017.07.027_bb0125","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR","volume":"64","author":"Petrosky","year":"2015","journal-title":"Morb. Mortal. Wkly Rep."},{"issue":"11","key":"10.1016\/j.ypmed.2017.07.027_bb0130","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.vaccine.2014.12.063","article-title":"Monitoring the impact of human papillomavirus vaccines on high-grade pre-invasive cervical lesions: designing a framework of linked immunization information system and cancer registry data in Michigan","volume":"33","author":"Potter","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ypmed.2017.07.027_bb0135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijc.28666","article-title":"Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort","volume":"135","author":"Roura","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.ypmed.2017.07.027_bb0140","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual report to the nation on the status of cancer, 1975\u20132012, featuring the increasing incidence of liver cancer","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ypmed.2017.07.027_bb0145","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinternmed.2010.134","article-title":"Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?","volume":"170","author":"Saraiya","year":"2010","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.ypmed.2017.07.027_bb0150","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ypmed.2013.01.020","article-title":"Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians","volume":"57","author":"Saraiya","year":"2013","journal-title":"Prev. Med."},{"issue":"6","key":"10.1016\/j.ypmed.2017.07.027_bb0155","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.ypmed.2017.07.027_bb0160","first-page":"914","article-title":"Report of the 1991 Bethesda Workshop","volume":"16","author":"The Bethesda System for reporting cervical\/vaginal cytologic diagnoses","year":"1992","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.ypmed.2017.07.027_bb0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0962280206070621","article-title":"Efficient interval estimation for age-adjusted cancer rates","volume":"15","author":"Tiwari","year":"2006","journal-title":"Stat. Methods Med. Res."},{"issue":"10 Suppl","key":"10.1016\/j.ypmed.2017.07.027_bb0170","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/cncr.23756","article-title":"Burden of cervical cancer in the United States, 1998\u20132003","volume":"113","author":"Watson","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2017.07.027_bb0175","series-title":"Audit of case finding completeness and accuracy in four registries collecting cervical cancer precursors","author":"Watson","year":"2015"},{"key":"10.1016\/j.ypmed.2017.07.027_bb0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ypmed.2017.05.004","article-title":"National assessment of HPV and Pap tests: changes in cervical cancer screening, National Health Interview Survey","volume":"100","author":"Watson","year":"2017","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2017.07.027_bb0185","series-title":"Surveillance for Certain Health Behaviors Among States and Selected Local Areas\u2014Behavioral Risk Factor Surveillance System, United States, 2011. MMWR. Surveillance summaries: Morbidity and Mortality Weekly Report. Surveillance Summaries\/CDC","first-page":"1","volume":"63(9)","author":"Xu","year":"2014"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743517302748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743517302748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T17:55:54Z","timestamp":1535565354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743517302748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":35,"alternative-id":["S0091743517302748"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.07.027","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance of high-grade cervical cancer precursors (CIN III\/AIS) in four population-based cancer registries, United States, 2009\u20132012","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}